FINWIRES · TerminalLIVE
FINWIRES

GE Vernova Benefiting From Strong Demand, Margin Upside, Buybacks, Oppenheimer Says

By

GE Vernova (GEV) continues to benefit from strong demand, a wider customer base, better pricing, software gains, rising cash flow, and buybacks, Oppenheimer said in a note Thursday.

The brokerage said Q1 orders of $18.3 billion came in well above its $13.5 billion estimate, showing demand remains strong and broad across customers and regions, and the company's integrated offerings are helping it win more business, especially in electrification, where data center orders in the quarter moved ahead of all of fiscal 2025.

GE Vernova's software business at both the product and operating levels still looks undervalued and could help margins beat forecasts, while strong cash generation and ongoing stock buybacks should continue to support the shares, according to the note.

Management's steady price increases and focus on efficiency should support earnings, the brokerage said, noting that the company raised its fiscal 2026 revenue, margin, and free cash flow guidance.

Oppenheimer kept its outperform rating on the stock and raised its price target to $1,303 from $1,139.

Shares of GE Vernova were up 2.6% in Thursday trading.

Price: $1157.05, Change: $+29.49, Percent Change: +2.62%

Related Articles

Wire

New Hope Completes AU$300 Million Convertible Notes Offering

New Hope (ASX:NHC) completed a AU$300 million issuance of 2.625% senior unsecured convertible notes due 2032 and the concurrent repurchase of AU$293.3 million of its existing 2029 convertible notes, according to a Thursday filing with the Australian bourse.The new notes are expected to be listed on the Singapore Exchange Securities Trading on or around Thursday, per the filing.The repurchased 2029 notes, which account for around 98% of the outstanding notes, will be cancelled under their terms, the filing said. The company also plans to redeem the remaining AU$6.7 million of notes at par plus accrued interest prior to maturity.

ASX:NHC
Wire

Telix Pharmaceuticals Settles Issue of $600 Million Convertible Notes

Telix Pharmaceuticals (ASX:TLX) said it settled the issue of $600 million in 1.50% convertible notes due 2031, according to a Thursday Australian bourse filing.The convertible notes are expected to be listed on the Official List of the Singapore Exchange Securities Trading on Thursday.In the same filing, the company said that the repurchase of around AU$637 million in principal of the AU$650 million worth of 2.375% convertible bonds due 2029 is "substantially complete."After the repurchase, given that less than 15% in aggregate principal amount of the existing bonds will remain outstanding, Telix said it plans to exercise its right to repurchase and cancel all of the remaining existing bonds at their principal amount.

ASX:TLX
Wire

Century Communities Q1 Adjusted Earnings, Revenue Fall

Century Communities (CCS) reported Q1 adjusted earnings late Wednesday of $0.88 per diluted share, down from $1.39 a year earlier.Three analysts polled by FactSet expected $0.59.Revenue for the three months ended March 31 fell to $789.7 million from $903.2 million a year earlier.Four analysts surveyed by FactSet expected $807.7 million.

$CCS